Performance analysis of Reneo Pharmaceuticals (OKUR)
Annual Return
Since Oct 7, 2024, OKUR has had an average annual return of -59.38%, underperforming the benchmark SPY, which returned +20% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +44.82% | -66.28% | -53.89% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.94% | +2.61% | +52.79% | +27.30% | -20.31% | +0% | +44.82% | ||||||
| 2025 | -28.48% | -17.59% | -15.16% | -42.11% | +1.65% | -5.53% | -7.57% | +24.47% | +0% | +23.25% | -11.22% | -3.66% | -66.28% |
| 2024 | -6.17% | -11.88% | -44.23% | -53.89% |
Drawdown analysis of Reneo Pharmaceuticals (OKUR)
The maximum drawdown for the OKUR was -90.48%, occurring on May 14, 2025. This drawdown has not yet recovered.
The current OKUR drawdown is -78.14%.
Since Oct 7, 2024 OKUR has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.48% | Oct 8, 2024 | 149 | May 14, 2025 | Ongoing | Ongoing | Ongoing |